NeuroThera Labs Inc. has increased its non-brokered private placement to issue up to 45 million units at C$0.12 each, aiming to raise approximately C$5.4 million. Each unit includes one common share and one warrant exercisable at C$0.16 for 36 months, extended from the previous 24 months. The company plans to use the funds for working capital, debt repayment, and corporate expenses. The offering is subject to TSX Venture Exchange approval and includes provisions for accelerated warrant expiry if listed on Nasdaq.
Grabar Law Office is investigating claims against officers and directors of First Solar, Hub Group, Navan, and ZoomInfo for alleged breaches of fiduciary duties and securities fraud. The investigations focus on misleading statements and omissions rel...
A longtime ENS delegate, Alex Netto, has criticized a governance proposal that would shift operational control from the ENS DAO to the ENS Foundation, warning it could mark the downfall of the Ethereum Name Service as a decentralized project. The pro...
Kuehn Law is investigating Five9, Inc. officers and directors for allegedly misleading shareholders by misrepresenting the company's business strength and bookings. The lawsuit claims Five9 overstated its new business growth and failed to disclose ch...
Chris Larsen, Ripple's co-founder, invested in American Perpetuals Exchange Corp. (APEC), a derivatives startup founded by Senator Kirsten Gillibrand's son, Theodore Gillibrand. APEC raised $30 million, valuing it at $300 million, and plans to offer ...
President Donald Trump stated in a CNBC interview that Federal Reserve Chairman Kevin Warsh must do what is necessary despite facing a 'hostile' Fed board. Trump declined to give specific advice following the latest U.S. jobs report but emphasized Wa...
